Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143969 |
| CAS No | NA |
| Mol.F. | C22H25N3O3 |
| Mol.Wt. | 379.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143970 |
| CAS No | NA |
| Mol.F. | C22H24N4O4 |
| Mol.Wt. | 408.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143971 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143972 |
| CAS No | NA |
| Mol.F. | C6H8N4O3 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143973 |
| CAS No | NA |
| Mol.F. | C7H14N2O2 |
| Mol.Wt. | 158.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143974 |
| CAS No | NA |
| Mol.F. | C8H10N2O |
| Mol.Wt. | 150.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143975 |
| CAS No | NA |
| Mol.F. | C5H8N2O2 |
| Mol.Wt. | 128.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143976 |
| CAS No | NA |
| Mol.F. | C4H5N3O |
| Mol.Wt. | 111.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143977 |
| CAS No | 1822857-11-3 |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143978 |
| CAS No | NA |
| Mol.F. | C4H10ClN3O |
| Mol.Wt. | 151.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143979 |
| CAS No | 83008-57-5 |
| Mol.F. | C3H8N4O |
| Mol.Wt. | 116.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143980 |
| CAS No | 1354380-71-4 |
| Mol.F. | C3H7N5O2 |
| Mol.Wt. | 145.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143981 |
| CAS No | NA |
| Mol.F. | C6H14N4O |
| Mol.Wt. | 158.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143982 |
| CAS No | NA |
| Mol.F. | C13H17N5O |
| Mol.Wt. | 259.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143983 |
| CAS No | 52764-44-0 |
| Mol.F. | C5H12N4O |
| Mol.Wt. | 144.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |